A new study finds that under 30% of radiology-focused AI/ML devices authorized by the FDA had clinical testing prior to authorization.
Key Details
- 1FDA has cleared over 1,000 AI/ML devices, most for radiology.
- 2Research published in JAMA Network Open reviewed almost 1,000 algorithms approved from 1995 to June 2024.
- 3Of 723 radiology devices, fewer than 30% underwent any form of clinical testing.
- 4Very few devices were subject to prospective trials before clearance.
- 5Authors highlight a lack of standards for safety and efficacy in FDA authorization of AI/ML devices.
Why It Matters
The rapid proliferation of AI/ML devices in radiology without adequate clinical validation raises concerns about patient safety and efficacy. The findings emphasize an urgent need for more rigorous regulatory oversight and defined testing standards for imaging AI tools.
Source
Radiology Business
Related News
•AuntMinnie
Toronto Study: LLMs Must Cite Sources for Radiology Decision Support
University of Toronto researchers found that large language models (LLMs) such as DeepSeek V3 and GPT-4o offer promising support for radiology decision-making in pancreatic cancer when their recommendations cite guideline sources.
•AuntMinnie
AI Model Using Mammograms Enhances Five-Year Breast Cancer Risk Assessment
A new image-only AI model more accurately predicts five-year breast cancer risk than breast density alone, according to multinational research presented at RSNA 2025.
•Radiology Business
AI Model Uses CT Scans to Reveal Biomarker for Chronic Stress
Researchers developed an AI model to measure chronic stress using adrenal gland volume on routine CT scans.